Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion type Assertion NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_head.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion description "[The MCT1 inhibitor CHC exhibited anti-tumoral and anti-angiogenic activity in gliomas and, of importance, enhanced the effect of temozolomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion evidence source_evidence_literature NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion SIO_000772 23258846 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion wasDerivedFrom befree-20140225 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.
- NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_assertion wasGeneratedBy ECO_0000203 NP491513.RAmWdC9b-2JdbfEKI1V9V6ez4wlaiO-EXHV0-PCPxK7ds130_provenance.